ABBOTT LABORATORIES — Director's Dealing 2017

Jul 26, 2017

SEC Form 4/A — Form 4/A

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-01-04

Reporting Person: Fain Eric S (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-04	Common shares without par value	A	114240	—	Acquired	116333	Direct

Footnotes

F1: Due to an administrative error that occurred prior to Abbott's acquisition of St. Jude Medical, Inc., the Form 4 filed on January 6, 2017 underreported the Abbott shares received by the reporting person pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Inc., Vault Merger Sub, Inc., and Vault Merger Sub, LLC, by 413 shares.

F2: On January 4, 2017, Abbott Laboratories ("Abbott") acquired St. Jude Medical, Inc. ("St. Jude Medical") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the "Merger Agreement"). Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott.